Pyrazinamide: Clinical Trials

9 trials of Pyrazinamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 not yet recruiting, 1 unknown. 9 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 19Completed 7, Not yet recruiting 1, Unknown 1
Phase 21Completed 1

Follow Pyrazinamide: new trials by email Literature Review of Pyrazinamide trials Research Report on Pyrazinamide

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , Karachi
Silymarin 420 mg, N Acetyl Cysteine, Rifampicin (RMP) Ethambutol (E) Isoniazid (H) Pyrazinamid (Z) - Drug Induced Liver Injury, Tuberculosis (TB)
Phase 1Not yet recruitingLiaquat National Hospital & Medical College4102025-07-012025-07-10
Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy
Nivaquine ® (Chloroquine) - Tuberculosis Infection
Phase 1UnknownUniversity of Zurich162022-01-042024-07-01
BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
BTZ-043, Rifafour e-275®, Probe Drug Cocktail - Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis
Phase 1 / Phase 2CompletedMichael Hoelscher782019-11-152026-08-31
Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy Volunteers
Pyrazinamide, Allopurinol - Tuberculosis
Phase 1CompletedNational University Hospital, Singapore122016-02-012017-04-13
Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers
Celecoxib, Rifampicin, Pyrazinamide - Tuberculosis
Phase 1CompletedNational University Hospital, Singapore182015-11-012017-04-13
PK Study of Anti-TB Drugs
Isoniazid (H), Rifampicin (R), Pyrazinamide (Z) - Tuberculosis
Phase 1CompletedUniversity of Oxford612015-07-072018-10-03
Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents
Levofloxacin and Streptomycin added, Moxifloxacin and Kanamycin added - Healthy
Phase 1CompletedSeoul National University Hospital162013-11-012014-05-01
Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis
Rifampicin, Isoniazid, Pyrazinamide - Tuberculosis
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)192008-12-292019-12-09
Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis
Nelfinavir mesylate, Ethambutol hydrochloride, Isoniazid - HIV Infections, Tuberculosis
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)442008-09-11

Conditions studied

Tuberculosis (7)  ·  AIDS-Related Opportunistic Infections (1)  ·  Chemical and Drug Induced Liver Injury (1)  ·  Gram-Positive Bacterial Infections (1)  ·  HIV Infections (1)  ·  Latent Tuberculosis (1)  ·  Tuberculosis, Pulmonary (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  National University Hospital, Singapore (2)  ·  Liaquat National Hospital & Medical College (1)  ·  Michael Hoelscher (1)  ·  Seoul National University Hospital (1)  ·  University of Oxford (1)  ·  University of Zurich (1)

Countries

Singapore (2)  ·  South Korea (2)  ·  South Africa (1)  ·  Switzerland (1)  ·  Thailand (1)  ·  United States (1)

Top investigators

Nicholas Paton (2)  ·  Andreas Diacon, Prof (1)  ·  Ariba Sultan (1)  ·  Clifton E Barry, Ph.D. (1)  ·  Constance Benson (1)  ·  Diane Havlir (1)  ·  Marisa Kaelin, Dr. med. (1)  ·  Michael Hoelscher, Prof (1)

Results publications

PMID 25987620, PMID 26400476, PMID 28739782, PMID 30939136, PMID 39793592, PMID 42156227, PMID 42568101